PAXALISIB
21-109
Phase 2 small_molecule active
Quick answer
PAXALISIB for Primary Central Nervous System Lymphoma is a Phase 2 program (small_molecule) at KAZIA THERAPEUTICS LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KAZIA THERAPEUTICS LTD
- Indication
- Primary Central Nervous System Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active